Xylem (NYSE: XYL), a leading global water technology company, announced that it will acquire Evoqua, a leader in mission-critical water treatment solutions and services, in an all-stock transaction worth $7.5 billion.

The merger brings together two companies with a shared focus on solving global water challenges, and will allow for the development and delivery of a more comprehensive range of innovative solutions. 

Evoqua shareholders will receive 0.480 shares of Xylem for each Evoqua share, representing a value of $52.89 per share or a 29 percent premium based on Xylem and Evoqua closing prices as of January 20, 2023.

Upon closing, Xylem shareholders will own approximately 75 percent and Evoqua shareholders will own approximately 25 percent of the combined company on a fully diluted basis.

The merger is expected to close in mid-2023 and is subject to regulatory and shareholder approvals.

Patrick Decker, President and CEO of Xylem stated: “The combined company delivers an unparalleled portfolio of advanced technologies, integrated services and application expertise across the water cycle.”

Ron Keating, Evoqua's President and CEO added: This combination provides a platform to leverage our combined strengths and increase our impact to better address the most pressing and increasingly complex global water challenges.”

Xylem is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation.

Shares of Xylem trade on the NYSE under the ticker symbol XYL and shares of Evoqua also trade on the NYSE under the ticker symbol AQUA.